Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of their mRNA targets. To characterize the DLBCL miRNome, we sequenced miRNAs fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Emilia L, Trinh, Diane L, Scott, David W, Chu, Andy, Krzywinski, Martin, Zhao, Yongjun, Robertson, A Gordon, Mungall, Andrew J, Schein, Jacqueline, Boyle, Merrill, Mottok, Anja, Ennishi, Daisuke, Johnson, Nathalie A, Steidl, Christian, Connors, Joseph M, Morin, Ryan D, Gascoyne, Randy D, Marra, Marco A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308918/
https://www.ncbi.nlm.nih.gov/pubmed/25723320
http://dx.doi.org/10.1186/s13059-014-0568-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308918/
https://www.ncbi.nlm.nih.gov/pubmed/25723320
http://dx.doi.org/10.1186/s13059-014-0568-y

Ejemplares similares